Advertisement

Risk for Specific Hematologic Cancers Down With GLP-1 Receptor Agonist Use in T2DM

0

GLP-1 RA use linked to lower risks for myelodysplastic syndromes, myeloproliferative neoplasms compared with metformin

Treating Male Partners Reduces Recurrence in Bacterial Vaginosis

0

Addition of antimicrobial therapy for male partners to treatment of women results in lower rate of recurrence

CDC to Study Vaccines and Autism, Despite Much Research Showing No Link

0
By I. Edwards HealthDay Reporter MONDAY, March 10, 2025 (HealthDay News) -- The U.S. Centers for Disease Control and Prevention (CDC) is preparing to study...

Recent Decade Saw No Change in Diabetes Prevalence in U.S. Adults

0

However, glycemic control worsened, with the trend most pronounced among younger adults aged 20 to 44 years

Makers of Wegovy & Zepbound Cut Prices for Those Without Insurance

0
By I. Edwards HealthDay Reporter FRIDAY, March 7, 2025 (HealthDay News) -- The makers of two popular weight-loss drugs — Wegovy and Zepbound — are...

No Link Seen Between Preop GLP-1 Receptor Agonist Use and Postop Aspiration Pneumonia

0

No significant difference seen in odds of postoperative pneumonia between adult GLP-1 receptor agonist users and nonusers

Intraoperative Remifentanil, Sufentanil Tied to Poor Postoperative Pain Experience

0

Other predictors of poor pain experience include American Society of Anesthesiologists 3 status, postoperative anxiolytic use, amnesia

Florida Seeks Patient Prescription Data

0
By I. Edwards HealthDay Reporter THURSDAY, March 6, 2025 (HealthDay News) -- Florida’s insurance regulator is demanding detailed prescription data on millions of patients, raising...

Lower Rates of Symptom Rebound Seen After H. Pylori Eradication in GERD

0

Significantly lower rates of symptom rebound and rebound severity seen four weeks after eradication for those with infection

FDA Approves TNKase for Acute Ischemic Stroke

0

The five-second intravenous bolus offers faster, simpler administration than Activase